FIP1L1-PDGFRA in chronic eosinophilic leukemia and BCR-ABL1 in chronic myeloid leukemia affect different leukemic cells. [electronic resource]
Producer: 20070413Description: 397-402 p. digitalISSN:- 0887-6924
- AC133 Antigen
- Antigens, CD -- analysis
- Antigens, CD34 -- analysis
- Antineoplastic Agents -- therapeutic use
- Benzamides
- Cell Lineage
- Chronic Disease
- Clone Cells -- enzymology
- Drug Resistance
- Eosinophils -- enzymology
- Erythrocytes -- enzymology
- Fusion Proteins, bcr-abl -- analysis
- Glycophorins -- analysis
- Glycoproteins -- analysis
- Granulocytes -- enzymology
- Hematopoietic Stem Cells -- enzymology
- Humans
- Hypereosinophilic Syndrome -- drug therapy
- Imatinib Mesylate
- Immunophenotyping
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Lymphocyte Subsets -- enzymology
- Megakaryocytes -- enzymology
- Monocytes -- enzymology
- Myeloid Cells -- enzymology
- Neoplastic Stem Cells -- enzymology
- Oncogene Proteins, Fusion -- analysis
- Peptides -- analysis
- Piperazines -- therapeutic use
- Protein Kinase Inhibitors -- therapeutic use
- Pyrimidines -- therapeutic use
- Receptor, Platelet-Derived Growth Factor alpha -- analysis
- Tumor Stem Cell Assay
- X Chromosome Inactivation
- mRNA Cleavage and Polyadenylation Factors -- analysis
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.